OS-062 Liver transplantation after downstaging of intermediate and advanced HCC with atezolizumab-bevacizumab: a prospective study (ImmunoXXL)

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-05-01 DOI:10.1016/S0168-8278(25)00377-0

Sherrie Bhoori, Licia Rivoltini, Valentina Bellia, Marianna Maspero, Jacopo de Cristofaro, Marco Bongini, Michela Dosi, Elisabetta Vergani, Giovanni Di Maio, Giuseppe Leoncini, Barbara Vergani, Nicolò Simonotti, Barbara Cappetti, Francesca Rini, Stefano Bergamini, Luca Lalli, Carlo Sposito, Vincenzo Mazzaferro

引用次数: 0

查看原文本刊更多论文

atezolizumab-bevacizumab治疗中晚期HCC后肝移植：一项前瞻性研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.